Edition:
United States

Ankur Banerjee

Common painkiller tied to increased risk of heart problems

Sep 21 2018

(Reuters Health) - The commonly used painkiller diclofenac may be linked with an increased risk of heart problems, a large Danish study suggests.

One in three U.S. teens text while driving, survey shows

Sep 10 2018

(Reuters Health) - One in three teen drivers in the U.S. text while driving, new survey data suggests. And the number may be higher in states where teens start driving at younger ages.

Artery damage seen in some teenage smokers, drinkers

Sep 07 2018

(Reuters Health) - Teenagers who smoke or who binge on alcohol have signs of artery damage by age 17, a recent study shows.

Lilly's Elanco unit expects IPO to raise up to $1.45 bln

Sep 06 2018

Eli Lilly & Co's Elanco Animal Health unit expects its initial public offering to raise up to $1.45 billion, betting on increased appetite among investors for animal health companies.

Severe fatty liver disease boosts risk for liver cancer

Sep 04 2018

(Reuters Health) - People with advanced cases of nonalcoholic fatty liver disease (NAFLD) may need to be watched for liver cancer, a large U.S. study suggests.

Morning sickness that plagued duchess doesn't usually recur

Aug 30 2018

(Reuters Health) - Three out of four women who suffer the severe form of morning sickness that afflicted the Duchess of Cambridge do not experience it in subsequent pregnancies, according to a Finnish study.

FDA approves Teva's generic of Mylan's EpiPen

Aug 18 2018

The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs. | Video

Glenview backs Cigna-Express Scripts deal after Icahn criticism

Aug 09 2018

Hedge fund Glenview Capital Management on Thursday backed health insurer Cigna Corp's deal to buy pharmacy benefit manager Express Scripts in the face of stiff opposition from activist investor Carl Icahn ahead of a shareholder vote.

CVS Health beats profit estimates, defends PBM business

Aug 08 2018

CVS Health Corp beat analysts' estimates for quarterly profit on Wednesday and the drugstore operator defended its pharmacy benefits management business in the face of the Trump administration's move to clamp down on escalating drug costs.

Icahn urges Cigna shareholders to vote against Express Scripts deal

Aug 07 2018

Activist investor Carl Icahn on Tuesday urged Cigna Corp shareholders to vote against the health insurer's $52 billion purchase of Express Scripts Holding Co , citing regulatory hurdles and the growing threat from Amazon. | Video

World News